泰安病治疗武汉哪家医院好-【济南癫痫病医院】,NFauFwHg,聊城什么医院治疗癫痫病好,山东济南看癫痫医院哪里好,滨州治疗儿童羊羔疯病哪家医院好,江苏儿童医院癫痫专病,潍坊癫痫病医院收费,河南癫痫病怎么治疗比较好
泰安病治疗武汉哪家医院好东营癫痫病应怎么治疗,山东省中医治疗癫痫病偏方,滨州预防癫痫疾病的方法是什么,聊城治疗效果好癫痫医院,聊城治羊羔疯病哪里好,菏泽治癫痫去哪家,滨州癫痫病好的治疗方法
BEIJING, Feb. 26 (Xinhua) -- China's Ministry of Education said Friday that 34.29 million students graduated from the country's higher-learning institutions between 2006 and 2010.Xu Mei, the ministry's spokeswoman, said the number is even more than that of the graduates in the 20 years prior to 2006 combined."During the 11th five-year plan period (2006-2010), higher education has become even more accessible to the general public. Higher-learning institutions provide a strong support of brain power and human resources to the social and economic development," Xu said.The "Outline of China's National Plan for Medium and Long-Term Education Reform and Development (2010-2020)," which was publicized last year, says "the strategic goals to be attained by 2020 are to basically modernize education; shape a learning society; and turn China into a country rich in human resources."
WASHINGTON, May 11 (Xinhua) -- Johns Hopkins University researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.The work, published Wednesday in the journal Science Translational Medicine, suggests that liver cells derived from so- called "induced-pluripotent stem cells (iPSCs)" could one day be used as an alternative to liver transplant in patients with serious liver diseases, bypassing long waiting lists for organs and concerns about immune system rejection of donated tissue."Our findings provide a foundation for producing functional liver cells for patients who suffer liver diseases and are in need of transplantation," says Yoon-Young Jang, assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center. "iPSC-derived liver cells not only can be generated in large amounts, but also can be tailored to each patient, preventing immune-rejection problems associated with liver transplants from unmatched donors or embryonic stem cells." A microsopic view shows human embryonic stem cells in various stages of differentiation into liver cells in this photo taken at Stanford University and released by the California Institute for Regenerative Medicine, March 9, 2009iPSCs are made from adult cells that have been genetically reprogrammed to revert to an embryonic stem cell-like state, with the ability to transform into different cell types. Human iPSCs can be generated from various tissues, including skin, blood and liver cells.Although the liver can regenerate in the body, end-stage liver failure caused by diseases like cirrhosis and cancers eventually destroy the liver's regenerative ability, Jang says. Currently, the only option for those patients is to receive a liver organ or liver cell transplant, a supply problem given the severe shortage of donor liver tissue for transplantation. In addition, mature liver cells and adult liver stem cells are difficult to isolate or grow in the laboratory, she says. By contrast, iPSCs can be made from a tiny amount of many kinds of tissue; and the embryonic stem- like iPSCs can grow in laboratory cultures indefinitely.For the study, Jang and colleagues generated human iPSCs from a variety of adult human cells, including liver cells, fibroblasts ( connective tissue cells), bone marrow stem cells and skin cells. They found that though the iPSCs overall were molecularly similar to each other and to embryonic stem cells, they retained a distinct molecular "signature" inherited from the cell of origin.
WASHINGTON, May 11 (Xinhua) -- Johns Hopkins University researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.The work, published Wednesday in the journal Science Translational Medicine, suggests that liver cells derived from so- called "induced-pluripotent stem cells (iPSCs)" could one day be used as an alternative to liver transplant in patients with serious liver diseases, bypassing long waiting lists for organs and concerns about immune system rejection of donated tissue."Our findings provide a foundation for producing functional liver cells for patients who suffer liver diseases and are in need of transplantation," says Yoon-Young Jang, assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center. "iPSC-derived liver cells not only can be generated in large amounts, but also can be tailored to each patient, preventing immune-rejection problems associated with liver transplants from unmatched donors or embryonic stem cells." A microsopic view shows human embryonic stem cells in various stages of differentiation into liver cells in this photo taken at Stanford University and released by the California Institute for Regenerative Medicine, March 9, 2009iPSCs are made from adult cells that have been genetically reprogrammed to revert to an embryonic stem cell-like state, with the ability to transform into different cell types. Human iPSCs can be generated from various tissues, including skin, blood and liver cells.Although the liver can regenerate in the body, end-stage liver failure caused by diseases like cirrhosis and cancers eventually destroy the liver's regenerative ability, Jang says. Currently, the only option for those patients is to receive a liver organ or liver cell transplant, a supply problem given the severe shortage of donor liver tissue for transplantation. In addition, mature liver cells and adult liver stem cells are difficult to isolate or grow in the laboratory, she says. By contrast, iPSCs can be made from a tiny amount of many kinds of tissue; and the embryonic stem- like iPSCs can grow in laboratory cultures indefinitely.For the study, Jang and colleagues generated human iPSCs from a variety of adult human cells, including liver cells, fibroblasts ( connective tissue cells), bone marrow stem cells and skin cells. They found that though the iPSCs overall were molecularly similar to each other and to embryonic stem cells, they retained a distinct molecular "signature" inherited from the cell of origin.
SAN FRANCISCO, May 3 (Xinhua) -- Apple Inc. announced on Tuesday that it has updated its iMac all-in-one desktop, adding Intel's next generation quad-core processors, Thunderbolt data ports and a new HD camera.Starting at 1,199 U.S. dollars, the new iMac is up to 70 percent faster and its new graphics deliver up to three times the performance of the previous generation, Apple said in a statement.The new iMac features quad-core Intel Core i5 processors with an upgrade option to Core i7 processors.The 21.5-inch model has a single Thunderbolt port while the 27- inch has two, in addition to four USB 2.0 inputs and a FireWire 800 port.Thunderbolt, which debuted with Apple's updated MacBook Pro notebooks in February, is also an Intel design bringing together high-speed data transfer and high-definition display onto a single cable. It can transfer a full-length HD movie in less than 30 seconds with a speed of 10 gigabits per second, which is twice the speed of USB 3.0, 12 times faster than FireWire 800 and up to 20 times faster than USB 2.0.The new iMac also includes a built-in FaceTime HD camera, which supports high-definition video calls, Apple said.
PARIS, May 17 (Xinhua) -- Arianespace has approved the preparation review of the third Ariane 5 flight, which is expected to lift two communication satellites on Friday from the spaceport in French Guiana, the European launching center said on Tuesday.The prior readiness review approved that "Ariane 5 is now cleared for its May 19 rollout from the Final Assembly Building to the ELA-3 launch zone, where it will be readied for liftoff on Friday at 5:38 p.m. local time in French Guiana," the space center said in a statement.This dual payload flight will orbit GSAT-8 and ST-2 satellites, with a combined mass of 8,190 kilo grams.Built by Japan's Mitsubishi Electric Company, ST-2 will be utilized by the ST-2 Satellite Ventures joint company of Singapore Telecommunications Ltd (SingTel) and Taiwan's Chunghwa Telecom Company Ltd. for Ku- and C-band relay services across the Middle East, Central Asia, India and Southeast Asia.The lighter passenger GSAT-8, built by the Indian Space Research Organization (ISRO), will serve to augment India's Ku- band relay capabilities and offer aircraft navigation assistance over Indian airspace and adjoining areas with its two-channel GAGAN system.The Arianespace started its 2011 busy year for heavy-lift Ariane 5 with the milestone launch of Europe's second Automated Transfer Vehicle (ATV) on February 16, and then a dual payload on April 22 that orbited Yahsat Y1A and Intelsat New Dawn satellites.